Doxorubicin triggers splenic contraction and irreversible dysregulation of COX and LOX that alters inflammation-resolution program in the myocardium

Heart functional and structural compendium of cardiosplenic and cardiorenal networks in acute and chronic heart failure pathology

(2018) Ganesh V. Halade et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarction

(2016) Ganesh V. Halade et al.   Aging-US

Drug-induced mitochondrial dysfunction and cardiotoxicity

(2015) Zoltán V Varga et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Human Lipoxygenase: Developments in its Structure, Function, Relevance to Diseases and Challenges in Drug Development

(2012) E. Skrzypczak-Jankun et al.   CURRENT MEDICINAL CHEMISTRY

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

(2012) Yanti Octavia et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: Mechanisms and implications

(2012) Lei Xi et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Cardioprotective activity of standardized extract ofFicus racemosastem bark against doxorubicin-induced toxicity

(2011) Faiyaz Ahmed et al.   PHARMACEUTICAL BIOLOGY

Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice

(2010) Kaushik Vedam et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Cyclooxygenases: structural and functional insights

(2008) Carol A. Rouzer et al.   JOURNAL OF LIPID RESEARCH